Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Wlodek, Christina ^a   Ali, Faisal R ^b   Lear, John T ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DICLOFENAC; EVEROLIMUS; FLUOROURACIL; IMIQUIMOD; METHYLAMINOLEVULINIC ACID; RAPAMYCIN; UNCLASSIFIED DRUG; PHOTOSENSITIZING AGENT; PLANT EXTRACT;

ACTINIC KERATOSIS; CRYOTHERAPY; DISEASE PREDISPOSITION; ERYTHEMA; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; PHOTODYNAMIC THERAPY; REVIEW; SAFETY; SKIN DEFECT; ULCER; IMMUNOSUPPRESSIVE TREATMENT; PHOTOCHEMOTHERAPY; RISK FACTOR; SKIN TUMOR; TREATMENT OUTCOME;

HUMANS; IMMUNOSUPPRESSION; KERATOSIS, ACTINIC; ORGAN TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLANT EXTRACTS; RISK FACTORS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84874616348     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/349526     Document Type: Review

References (82)

1. Madan V., Lear J. T., Szeimies R. M., Non-melanoma skin cancer. The Lancet 2010 375 9715 673 685 2-s2.0-76749096684 10.1016/S0140-6736(09)61196-X
2. Euvrard S., Kanitakis J., Pouteil-Noble C., Dureau G., Touraine J. L., Faure M., Claudy A., Thivolet J., Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. Journal of the American Academy of Dermatology 1995 33 2, part 1 222 229 2-s2.0-0029082804
3. Berg D., Otley C. C., Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. Journal of the American Academy of Dermatology 2002 47 1 1 17 2-s2.0-0036657493 10.1067/mjd.2002.125579
4. Hartevelt M. M., Bouwes Bavinck J. N., Kootte A. M., Vermeer B. J., Vandenbroucke J. P., Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990 49 3 506 509 2-s2.0-0025305050 (Pubitemid 20110465)
5. Jensen P., Hansen S., Moller B., Leivestad T., Pfeifer P., Geiran O., Fauchald P., Simonsen S., Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. Journal of the American Academy of Dermatology 1999 40 2 177 186 2-s2.0-0033007170 10.1016/S0190-9622(99)70185-4 (Pubitemid 29072794)
6. Stockfleth E., Ulrich C., Meyer T., Christophers E., Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results in Cancer Research 2002 160 251 258 2-s2.0-0036044014
7. Webb M. C., Compton F., Andrews P. A., Koffman G. G., Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplantation Proceedings 1997 29 1-2 828 830 2-s2.0-0030961527 10.1016/S0041-1345(96)00152-2 (Pubitemid 27125980)
8. Adamson R., Obispo E., Dychter S., Dembitsky W., Moreno-Cabral R., Jaski B., Gordon J., Hoagland P., Moore K., King J., Andrews J., Rich M., Daily P. O., High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplantation Proceedings 1998 30 4 1124 1126 2-s2.0-13144307084 10.1016/S0041-1345(98)00178-X (Pubitemid 28309508)
9. Martinez J. C., Otley C. C., Stasko T., Euvrard S., Brown C., Schanbacher C. F., Weaver A. L., Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Archives of Dermatology 2003 139 3 301 306 2-s2.0-0037341914 10.1001/archderm.139.3.301 (Pubitemid 36330577)
10. Wisgerhof H. C., Edelbroek J. R. J., De Fijter J. W., Haasnoot G. W., Claas F. H. J., Willemze R., Bavinck J. N. B., Subsequent squamous-and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors. Transplantation 2010 89 10 1231 1238 2-s2.0-77952888852 10.1097/TP.0b013e3181d84cdc
11. Euvrard S., Kanitakis J., Decullier E., Butnaru A. C., Lefrançois N., Boissonnat P., Sebbag L., Garnier J. L., Pouteil-Noble C., Cahen R., Morelon E., Touraine J. L., Claudy A., Chapuis F., Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006 81 8 1093 1100 2-s2.0-33646820007 10.1097/01.tp.0000209921. 60305.d9
12. Hariharan S., Johnson C. P., Bresnahan B. A., Taranto S. E., McIntosh M. J., Erratum: Improved graft survival after renal transplantation in the United States, 1988 to 1996. New England Journal of Medicine 1837 342 24 1837 1938 2-s2.0-0034658753 10.1056/NEJM200006153422414
13. Basset-Seguin N., Baumann Conzett K., Gerritsen M. J. P., Gonzalez H., Haedersdal M., Hofbauer G. F. L., Photodynamic therapy for actinic keratosis in organ transplant patients. Journal of the European Academy of Dermatology and Venereology, 2011. In press
14. Lebwohl M. G., Rosen T., Stockfleth E., The role of human papillomavirus in common skin conditions: current viewpoints and therapeutic options. Cutis 2010 86 5, supplement 1-11 1 12 2-s2.0-79952221929
15. Harwood C. A., Proby C. M., Human papillomaviruses and non-melanoma skin cancer. Current Opinion in Infectious Diseases 2002 15 2 101 114 2-s2.0-0036208342 (Pubitemid 34272294)
16. Yarosh D. B., Canning M. T., Teicher D., Brown D. A., After sun reversal of DNA damage: enhancing skin repair. Mutation Research 2005 571 1-2 57 64 2-s2.0-14644433144 10.1016/j.mrfmmm.2004.06.058 (Pubitemid 40313432)
17. Yarosh D. B., Pena A. V., Nay S. L., Canning M. T., Brown D. A., Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation. Journal of Investigative Dermatology 2005 125 5 1020 1025 2-s2.0-32844468634 10.1111/j.0022-202X.2005.23858.x
18. André N., Roquelaure B., Conrath J., Molecular effects of cyclosporine and oncogenesis: a new model. Medical Hypotheses 2004 63 4 647 652 2-s2.0-8444223428 10.1016/j.mehy.2004.03.030 (Pubitemid 39485832)
19. Hojo M., Morimoto T., Maluccio M., Asano T., Morimoto K., Lagman M., Shimbo T., Suthanthiran M., Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999 397 6719 530 534 2-s2.0-0033545299 10.1038/17401 (Pubitemid 29093252)
20. Guba M., Graeb C., Jauch K. W., Geissler E. K., Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004 77 12 1777 1782 2-s2.0-2442635905 10.1097/01.TP.0000120181. 89206.54 (Pubitemid 38822196)
21. O'Donovan P., Perrett C. M., Zhang X., Montaner B., Xu Y. Z., Harwood C. A., McGregor J. M., Walker S. L., Hanaoka F., Karran P., Medicine: azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005 309 5742 1871 1874 2-s2.0-24944519200 10.1126/science.1114233 (Pubitemid 41325100)
22. Rival-Tringali A. L., Euvrard S., Decullier E., Claudy A., Faure M., Kanitakis J., Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas. Anticancer Research 2009 29 6 1927 1932 2-s2.0-67650866726
23. Frezza E. E., Fung J. J., Van Thiel D. H., Non-lymphoid cancer after liver transplantation. Hepato-Gastroenterology 1997 44 16 1172 1181 2-s2.0-0030849689 (Pubitemid 27326179)
24. Caforio A. L. P., Fortina A. B., Piaserico S., Alaibac M., Tona F., Feltrin G., Pompei E., Testolin L., Gambino A., Volta S. D., Thiene G., Casarotto D., Peserico A., Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000 102 19, supplement 3 III222 III227 2-s2.0-2042505777
25. Ulrich C., Jürgensen J. S., Degen A., Hackethal M., Ulrich M., Patel M. J., Eberle J., Terhorst D., Sterry W., Stockfleth E., Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. British Journal of Dermatology 2009 161 supplement 3 78 84 2-s2.0-70349312806 10.1111/j.1365-2133. 2009.09453.x
26. Ulrich C., Kanitakis J., Stockfleth E., Euvrard S., Skin cancer in organ transplant recipients-where do we stand today? American Journal of Transplantation 2008 8 11 2192 2198 2-s2.0-53749099885 10.1111/j.1600-6143.2008. 02386.x
27. Szeimies R. M., Karrer S., Radakovic-Fijan S., Tanew A., Calzavara-Pinton P. G., Zane C., Sidoroff A., Hempel M., Ulrich J., Proebstle T., Meffert H., Mulder M., Salomon D., Dittmar H. C., Bauer J. W., Kernland K., Braathen L., Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. Journal of the American Academy of Dermatology 2002 47 2 258 262 2-s2.0-0036697139 10.1067/mjd.2002.119649
28. Braakhuis B. J. M., Tabor M. P., Kummer J. A., Leemans C. R., Brakenhoff R. H., A genetic explanation of slaughter's concept of field cancerization: evidence and clinical implications. Cancer Research 2003 63 8 1727 1730 2-s2.0-0037446974 (Pubitemid 36460827)
29. Mittelbronn M. A., Mullins D. L., Ramos-Caro F. A., Flowers F. P., Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. International Journal of Dermatology 1998 37 9 677 681 2-s2.0-0031755173 10.1046/j.1365-4362.1998.00467.x (Pubitemid 28428318)
30. Ulrich C., Hackethal M., Ulrich M., Howorka A., Forschner T., Sterry W., Stockfleth E., Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases. British Journal of Dermatology 2007 156 supplement s3 40 42 2-s2.0-34247359625 10.1111/j.1365-2133.2007.07864.x (Pubitemid 46632515)
31. Kurwa H. A., Yong-Gee S. A., Seed P. T., Markey A. C., Barlow R. J., A randomized paired comparison of photodynamic therapy and topical 5- fluorouracil in the treatment of actinic keratoses. Journal of the American Academy of Dermatology 1999 41 3, part 1 414 418 2-s2.0-0032845672 10.1016/S0190-9622(99) 70114-3 (Pubitemid 29418508)
32. Dragieva G., Hafner J., Dummer R., Schmid-Grendelmeier P., Roos M., Prinz B. M., Burg G., Binswanger U., Kempf W., Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004 77 1 115 121 2-s2.0-1642566020 10.1097/01.TP.0000107284. 04969.5C (Pubitemid 38116882)
33. Szeimies R. M., Gerritsen M. J. P., Gupta G., Paul Ortonne J., Serresi S., Bichel J., Lee J. H., Fox T. L., Alomar A., Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. Journal of the American Academy of Dermatology 2004 51 4 547 555 2-s2.0-4644304377 10.1016/j.jaad.2004.02.022 (Pubitemid 39278073)
34. Korman N., Moy R., Ling M., Matheson R., Smith S., McKane S., Lee J. H., Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Archives of Dermatology 2005 141 4 467 473 2-s2.0-17444394323 10.1001/archderm.141.4.467 (Pubitemid 40547405)
35. Ulrich C., Bichel J., Euvrard S., Guidi B., Proby C. M., Van De Kerkhof P. C. M., Amerio P., Rønnevig J., Slade H. B., Stockfleth E., Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients. British Journal of Dermatology 2007 157 supplement s2 25 31 2-s2.0-36549087129 10.1111/j.1365-2133.2007.08269.x (Pubitemid 350179626)
36. De Berker D., McGregor J. M., Hughes B. R., Guidelines for the management of actinic keratoses. British Journal of Dermatology 2007 156 2 222 230 2-s2.0-33846221473 10.1111/j.1365-2133.2006.07692.x (Pubitemid 46098882)
37. Ulrich C., Johannsen A., Röwert-Huber J., Ulrich M., Sterry W., Stockfleth E., Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses. European Journal of Dermatology 2010 20 4 482 488 2-s2.0-77954697873 10.1684/ejd.2010.1010
38. Pariser D. M., Lowe N. J., Stewart D. M., Jarratt M. T., Lucky A. W., Pariser R. J., Yamauchi P. S., Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. Journal of the American Academy of Dermatology 2003 48 2 227 232 2-s2.0-0037328759 10.1067/mjd.2003.49 (Pubitemid 36232321)
39. Freeman M., Vinciullo C., Francis D., Spelman L., Nguyen R., Fergin P., Thai K. E., Murrell D., Weightman W., Anderson C., Reid C., Watson A., Foley P., A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. Journal of Dermatological Treatment 2003 14 2 99 106 2-s2.0-12444321967 10.1080/09546630305538 (Pubitemid 36648700)
40. Braathen L. R., Szeimies R. M., Basset-Seguin N., Bissonnette R., Foley P., Pariser D., Roelandts R., Wennberg A. M., Morton C. A., Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. Journal of the American Academy of Dermatology 2007 56 1 125 143 2-s2.0-33845701344 10.1016/j.jaad.2006.06.006 (Pubitemid 44969292)
41. Morton C., Campbell S., Gupta G., Keohane S., Lear J., Zaki I., Walton S., Kerrouche N., Thomas G., Soto P., Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. British Journal of Dermatology 2006 155 5 1029 1036 2-s2.0-33749826602 10.1111/j.1365-2133.2006.07470.x (Pubitemid 44564515)
42. Perrett C. M., McGregor J. M., Warwick J., Karran P., Leigh I. M., Proby C. M., Harwood C. A., Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. British Journal of Dermatology 2007 156 2 320 328 2-s2.0-33846248756 10.1111/j.1365-2133.2006.07616.x (Pubitemid 46095961)
43. Guleng G. E., Helsing P., Photodynamic therapy for basal cell carcinomas in organ-transplant recipients. Clinical and Experimental Dermatology 2012 37 4 367 369 2-s2.0-84861199507 10.1111/j.1365-2230.2011.04248.x
44. Smits T., Kleinpenning M. M., Blokx W. A. M., van de Kerkhof P. C. M., van Erp P. E. J., Gerritsen M. J. P., Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. Journal of the American Academy of Dermatology 2007 57 5 824 831 2-s2.0-35148864521 10.1016/j.jaad.2007.06.031 (Pubitemid 47553081)
45. Gerritsen M. J. P., Smits T., Kleinpenning M. M., Van De Kerkhof P. C. M., Van Erp P. E. J., Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 2009 218 3 193 202 2-s2.0-62049083991 10.1159/000183753
46. Berroeta L., Clark C., Dawe R. S., Ibbotson S. H., Fleming C. J., A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma. British Journal of Dermatology 2007 157 2 401 403 2-s2.0-34447506387 10.1111/j.1365-2133.2007.07996.x (Pubitemid 47083846)
47. Souza C. S., Neves A. B. S., Felício L. A. B., Ferreira J., Kurachi C., Bagnato V. S., Optimized photodynamic therapy with systemic photosensitizer following debulking technique for nonmelanoma skin cancers. Dermatologic Surgery 2007 33 2 194 198 2-s2.0-33846787151 10.1111/j.1524-4725. 2006.33038.x (Pubitemid 46208112)
48. Soler A. M., Warloe T., Berner A., Giercksky K. E., A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. British Journal of Dermatology 2001 145 3 467 471 2-s2.0-0034790334 10.1046/j.1365-2133.2001.04407.x (Pubitemid 32953705)
49. Kleinpenning M. M., Kanis J. H., Smits T., Van Erp P. E. J., Van De Kerkhof P., Gerritsen R. M. J. P., The effects of keratolytic pretreatment prior to fluorescence diagnosis and photodynamic therapy with aminolevulinic acid-induced porphyrins in psoriasis. Journal of Dermatological Treatment 2010 21 4 245 251 2-s2.0-77953206693 10.3109/09546630903271548
50. Hædersdal M., Sakamoto F. H., Farinelli W. A., Doukas A. G., Tam J., Anderson R. R., Fractional CO2 laser-assisted drug delivery. Lasers in Surgery and Medicine 2010 42 2 113 122 2-s2.0-77249141050 10.1002/lsm.20860
51. Fang J. Y., Lee W. R., Shen S. C., Fang Y. P., Hu C. H., Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. British Journal of Dermatology 2004 151 1 132 140 2-s2.0-4043119712 10.1111/j.1365-2133. 2004.06051.x (Pubitemid 39061290)
52. Piaserico S., Belloni Fortina A., Rigotti P., Rossi B., Baldan N., Alaibac M., Marchini F., Topical photodynamic therapy of actinic keratosis in renal transplant recipients. Transplantation Proceedings 2007 39 6 1847 1850 2-s2.0-34547578193 10.1016/j.transproceed.2007.05.040 (Pubitemid 47198804)
53. Dragieva G., Prinz B. M., Hafner J., Dummer R., Burg G., Binswanger U., Kempf W., A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. British Journal of Dermatology 2004 151 1 196 200 2-s2.0-4043164838 10.1111/j.1365-2133.2004.06054.x (Pubitemid 39061299)
54. Bagazgoitia L., Cuevas Santos J., Juarranz A., Jaén P., Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers. British Journal of Dermatology 2011 165 1 144 151 2-s2.0-79959702219 10.1111/j.1365-2133.2011.10270.x
55. Castano A. P., Mroz P., Hamblin M. R., Photodynamic therapy and anti-tumour immunity. Nature Reviews Cancer 2006 6 7 535 545 2-s2.0-33745537921 10.1038/nrc1894 (Pubitemid 43980542)
56. Kanitakis J., Alhaj-Ibrahim L., Euvrard S., Claudy A., Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases. Archives of Dermatology 2003 139 9 1133 1137 2-s2.0-0141596246 10.1001/archderm.139.9.1133 (Pubitemid 37128374)
57. Willey A., Mehta S., Lee P. K., Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatologic Surgery 2010 36 5 652 658 2-s2.0-77951293600 10.1111/j.1524-4725.2009.01384.x
58. Wulf H. C., Pavel S., Stender I., Ahb Bakker-Wensveen C., Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Dermato-Venereologica 2006 86 1 25 28 2-s2.0-33744729650 10.1080/00015550510042868 (Pubitemid 46939784)
59. Wennberg A. M., Stenquist B., Stockfleth E., Keohane S., Lear J. T., Jemec G., Mork C., Christensen E., Kapp A., Solvsten H., Talme T., Berne B., Forschner T., Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation 2008 86 3 423 429 2-s2.0-52049107209 10.1097/TP.0b013e318180731e
60. Schleier P., Hyckel P., Berndt A., Bode H. P., Albrecht V., Hindermann W., Kosmehl H., Zenk W., Schumann D., Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients. Journal of Cancer Research and Clinical Oncology 2004 130 5 279 284 2-s2.0-2542439897 10.1007/s00432-003-0539-2 (Pubitemid 38680269)
61. Perrett C. M., Tan S. K., Cerio R., Goldsmith P. C., McGregor J. M., Proby C. M., Harwood C. A., Treatment of basal cell carcinoma with topical methylaminolaevulinate photodynamic therapy in an organ-transplant recipient. Clinical and Experimental Dermatology 2006 31 1 146 147 2-s2.0-33646077218
62. Gollnick S. O., Evans S. S., Baumann H., Owczarczak B., Maier P., Vaughan L., Wang W. C., Unger E., Henderson B. W., Role of cytokines in photodynamic therapy-induced local and systemic inflammation. British Journal of Cancer 2003 88 11 1772 1779 2-s2.0-0038265923 10.1038/sj.bjc.6600864 (Pubitemid 36760423)
63. Garg A. D., Nowis D., Golab J., Agostinis P., Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis 2010 15 9 1050 1071 2-s2.0-77956927110 10.1007/s10495-010-0479-7
64. Matthews Y. J., Damian D. L., Topical photodynamic therapy is immunosuppressive in humans. British Journal of Dermatology 2010 162 3 637 641 2-s2.0-76949092419 10.1111/j.1365-2133.2009.09562.x
65. Nobbe S., Trüeb R. M., French L. E., Hofbauer G. F. L., Herpes simplex virus reactivation as a complication of photodynamic therapy. Photodermatology Photoimmunology and Photomedicine 2011 27 1 51 52 2-s2.0-78650764293 10.1111/j.1600-0781.2010.00552.x
66. Frost G. A., Halliday G. M., Damian D. L., Photodynamic therapy-induced immunosuppression in humans is prevented by reducing the rate of light delivery. Journal of Investigative Dermatology 2011 131 4 962 968 2-s2.0-79952763925 10.1038/jid.2010.429
67. Arits A. H. M. M., Van De Weert M. M., Nelemans P. J., Kelleners-Smeets N. W. J., Pain during topical photodynamic therapy: uncomfortable and unpredictable. Journal of the European Academy of Dermatology and Venereology 2010 24 12 1452 1457 2-s2.0-77957334668 10.1111/j.1468-3083.2010.03670.x
68. Paoli J., Halldin C., Ericson M. B., Wennberg A. M., Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses. Clinical and Experimental Dermatology 2008 33 5 559 564 2-s2.0-49649112920 10.1111/j.1365-2230.2008.02755.x
69. Halldin C. B., Paoli J., Sandberg C., Gonzalez H., Wennberg A. M., Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp. British Journal of Dermatology 2009 160 4 795 800 2-s2.0-62649092157 10.1111/j.1365-2133.2008.09024.x
70. Halldin C. B., Paoli J., Sandberg C., Ericson M. B., Wennberg A. M., Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses. Acta Dermato-Venereologica 2008 88 3 311 313 2-s2.0-44349111917 10.2340/00015555-0429 (Pubitemid 351743894)
71. Pagliaro J., Elliott T., Bulsara M., King C., Vinciullo C., Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment: a pilot study. Dermatologic Surgery 2004 30 1 63 66 2-s2.0-0842333121 10.1111/j.1524-4725.2004.30011.x (Pubitemid 38174032)
72. Wiegell S. R., Hædersdal M., Wulf H. C., Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Dermato-Venereologica 2009 89 2 145 149 2-s2.0-63049108866 10.2340/00015555-0568
73. Langan S. M., Collins P., Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. British Journal of Dermatology 2006 154 1 146 149 2-s2.0-33644902967 10.1111/j.1365-2133.2005. 06991.x (Pubitemid 43381334)
74. Rosen R. H., Gupta A. K., Tyring S. K., Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. Journal of the American Academy of Dermatology 2012 66 3 486 493 2-s2.0-84862752123 10.1016/j.jaad.2010. 12.038
75. Challacombe J. M., Suhrbier A., Parsons P. G., Jones B., Hampson P., Kavanagh D., Rainger G. E., Morris M., Lord J. M., Le T. T. T., Diem H. L., Ogbourne S. M., Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate. Journal of Immunology 2006 177 11 8123 8132 2-s2.0-33751583347 (Pubitemid 44846331)
76. Ali F. R., Wlodek C., Lear J. T., The role of ingenol mebutate in the treatment of actinic keratoses. Dermatology & Therapy 2012 2 1 8
77. Lebwohl M., Swanson N., Anderson L. L., Melgaard A., Xu Z., Berman B., Ingenol mebutate gel for actinic keratosis. The New England Journal of Medicine 2012 366 11 1010 1019 2-s2.0-65749118370 10.1056/NEJMoa1111170
78. Jäger S., Laszczyk M. N., Scheffler A., A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex). Molecules 2008 13 12 3224 3235 2-s2.0-58149240781 10.3390/molecules13123224
79. Huyke C., Reuter J., Rödig M., Kersten A., Laszczyk M., Scheffler A., Nashan D., Schempp C., Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study. JDDG 2009 7 2 128 134 2-s2.0-59249107100 10.1111/j.1610-0387.2008.06865.x
80. Corden K. B., Gorski K. S., Gibson S. J., Kedl R. M., Kieper W. C., Qiu X., Tomai M. A., Alkan S. S., Vasilakos J. P., Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. Journal of Immunology 2005 174 3 1259 1268 2-s2.0-12444341806
81. Szeimies R. M., Bichel J., Ortonne J. P., Stockfleth E., Lee J., Meng T. C., A phase II dose-ranging study of topical resiquimod to treat actinic keratosis. British Journal of Dermatology 2008 159 1 205 210 2-s2.0-45749148641 10.1111/j.1365-2133.2008.08615.x (Pubitemid 351874499)
82. Berman B. Amini S. Pharmacotherapy of actinic keratosis: An update Expert Opinion on Pharmacotherapy 2012 13 13 1847-1871 2-s2.0-71449090905 10.1517/14656566.2012.716039